Article
Identification of novel prostate cancer genes in patients stratified by Gleason classification: Role of antitumoral genes
2 Mar 2022
Abstract excerpt
Prostate cancer (PCa) is a tumor with a great heterogeneity, both at a molecular and clinical level. Despite its global good prognosis, cases can vary from indolent to lethal metastatic and scientific efforts are aimed to discern those with worse outcomes. Current prognostic markers, as Gleason score, fall short when it comes to distinguishing these cases. Identification of new early biomarkers to enable a better...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
